INGALLS & SNYDER LLC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 49 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q4 2020$1,215,000
+6.5%
1,115,000
-0.3%
0.06%
-23.1%
Q3 2020$1,141,000
-7.8%
1,118,000
-0.5%
0.08%
+9.9%
Q2 2020$1,237,000
+8.1%
1,124,000
-0.2%
0.07%
-7.8%
Q1 2020$1,144,000
-11.0%
1,126,0000.0%0.08%
+10.0%
Q4 2019$1,285,000
+0.2%
1,126,0000.0%0.07%
+11.1%
Q3 2019$1,282,000
-8.4%
1,126,000
-4.7%
0.06%
-6.0%
Q2 2019$1,400,000
-11.9%
1,182,000
+0.7%
0.07%
-11.8%
Q1 2019$1,589,000
+11.2%
1,174,000
-11.9%
0.08%
+1.3%
Q4 2018$1,429,0001,332,0000.08%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2020
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 83,741,000$95,429,0006.49%
STEELHEAD PARTNERS LLC 52,496,000$59,911,0005.47%
SILVERBACK ASSET MANAGEMENT LLC 23,000,000$26,278,0004.02%
Castle Creek Arbitrage, LLC 10,734,000$12,253,0003.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$45,920,0002.81%
Sonora Investment Management, LLC 16,707,000$19,084,0001.99%
TFG Asset Management GP Ltd 8,500,000$9,718,0001.73%
Verition Fund Management LLC 27,901,000$31,890,0000.88%
SSI INVESTMENT MANAGEMENT LLC 7,872,000$8,977,0000.65%
SHENKMAN CAPITAL MANAGEMENT INC 4,780,000$5,514,0000.63%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders